Charles Van Sant

977 total citations
12 papers, 831 citations indexed

About

Charles Van Sant is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, Charles Van Sant has authored 12 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Charles Van Sant's work include Herpesvirus Infections and Treatments (8 papers), Cytomegalovirus and herpesvirus research (5 papers) and Virus-based gene therapy research (4 papers). Charles Van Sant is often cited by papers focused on Herpesvirus Infections and Treatments (8 papers), Cytomegalovirus and herpesvirus research (5 papers) and Virus-based gene therapy research (4 papers). Charles Van Sant collaborates with scholars based in United States and Germany. Charles Van Sant's co-authors include Bernard Roizman, Pascal Lopez, Rosario Leopardi, Ryan Hagglund, Yasushi Kawaguchi, Dimitri Semizarov, Rick Lesniewski, Mark G. Anderson, Sunil J. Advani and Edward T. Olejniczak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Vaccine.

In The Last Decade

Charles Van Sant

12 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Van Sant United States 10 628 338 308 244 116 12 831
Mary Jane Nicholl United Kingdom 13 694 1.1× 358 1.1× 223 0.7× 215 0.9× 117 1.0× 14 845
Ryan Hagglund United States 9 470 0.7× 254 0.8× 238 0.8× 172 0.7× 63 0.5× 9 587
Angela Pearson Canada 17 562 0.9× 276 0.8× 596 1.9× 222 0.9× 279 2.4× 37 1.2k
Elizabeth Wills United States 16 881 1.4× 360 1.1× 325 1.1× 261 1.1× 105 0.9× 20 1.1k
Marieke C. Verweij Netherlands 19 430 0.7× 464 1.4× 184 0.6× 96 0.4× 159 1.4× 21 853
Mira S. Chaurushiya United States 9 332 0.5× 201 0.6× 362 1.2× 138 0.6× 232 2.0× 9 728
Clare Davy Tanzania 11 419 0.7× 143 0.4× 224 0.7× 154 0.6× 147 1.3× 13 675
Margo H. Furman United States 12 622 1.0× 790 2.3× 248 0.8× 100 0.4× 173 1.5× 13 1.3k
Charles B. C. Hwang United States 18 734 1.2× 160 0.5× 205 0.7× 236 1.0× 235 2.0× 33 989
Nina Tavalai Germany 14 888 1.4× 395 1.2× 478 1.6× 180 0.7× 186 1.6× 14 1.1k

Countries citing papers authored by Charles Van Sant

Since Specialization
Citations

This map shows the geographic impact of Charles Van Sant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Van Sant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Van Sant more than expected).

Fields of papers citing papers by Charles Van Sant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Van Sant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Van Sant. The network helps show where Charles Van Sant may publish in the future.

Co-authorship network of co-authors of Charles Van Sant

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Van Sant. A scholar is included among the top collaborators of Charles Van Sant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Van Sant. Charles Van Sant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chichili, Gurunadh R., Ronald Smulders, Vicki Santos, et al.. (2022). Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years. Vaccine. 40(31). 4190–4198. 46 indexed citations
2.
Bonate, Peter L., Charles Van Sant, Erin C. Zook, et al.. (2020). Pharmacokinetics and Immunogenicity of ASP0113 in CMV‐Seronegative Dialysis Patients and CMV‐Seronegative and ‐Seropositive Healthy Subjects. Clinical Pharmacology in Drug Development. 9(4). 444–455. 3 indexed citations
3.
Lu, Xin, Ke Zhang, Charles Van Sant, John S. Coon, & Dimitri Semizarov. (2010). An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models. BMC Medical Genomics. 3(1). 23–23. 8 indexed citations
4.
Olejniczak, Edward T., Charles Van Sant, Mark G. Anderson, et al.. (2007). Integrative Genomic Analysis of Small-Cell Lung Carcinoma Reveals Correlates of Sensitivity to Bcl-2 Antagonists and Uncovers Novel Chromosomal Gains. Molecular Cancer Research. 5(4). 331–339. 53 indexed citations
5.
Sant, Charles Van, Gang Wang, Mark G. Anderson, et al.. (2007). Endothelin signaling in osteoblasts: global genome view and implication of the calcineurin/NFAT pathway. Molecular Cancer Therapeutics. 6(1). 253–261. 33 indexed citations
6.
Hagglund, Ryan, Charles Van Sant, Pascal Lopez, & Bernard Roizman. (2002). Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes. Proceedings of the National Academy of Sciences. 99(2). 631–636. 88 indexed citations
7.
Lopez, Pascal, Charles Van Sant, & Bernard Roizman. (2001). Requirements for the Nuclear-Cytoplasmic Translocation of Infected-Cell Protein 0 of Herpes Simplex Virus 1. Journal of Virology. 75(8). 3832–3840. 83 indexed citations
8.
Sant, Charles Van, Pascal Lopez, Sunil J. Advani, & Bernard Roizman. (2001). Role of Cyclin D3 in the Biology of Herpes Simplex Virus 1 ICP0. Journal of Virology. 75(4). 1888–1898. 36 indexed citations
9.
Sant, Charles Van, Ryan Hagglund, Pascal Lopez, & Bernard Roizman. (2001). The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity. Proceedings of the National Academy of Sciences. 98(15). 8815–8820. 99 indexed citations
10.
Sant, Charles Van, Yasushi Kawaguchi, & Bernard Roizman. (1999). A single amino acid substitution in the cyclin D binding domain of the infected cell protein no. 0 abrogates the neuroinvasiveness of herpes simplex virus without affecting its ability to replicate. Proceedings of the National Academy of Sciences. 96(14). 8184–8189. 62 indexed citations
11.
Kawaguchi, Yasushi, Charles Van Sant, & Bernard Roizman. (1998). Eukaryotic Elongation Factor 1δ Is Hyperphosphorylated by the Protein Kinase Encoded by the U L 13 Gene of Herpes Simplex Virus 1. Journal of Virology. 72(3). 1731–1736. 76 indexed citations
12.
Leopardi, Rosario, Charles Van Sant, & Bernard Roizman. (1997). The herpes simplex virus 1 protein kinase U S 3 is required for protection from apoptosis induced by the virus. Proceedings of the National Academy of Sciences. 94(15). 7891–7896. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026